Defining target populations to participate in trials of neuroprotective therapies requires identification, at an early stage, of individuals at risk of Parkinson’s disease (PD).
Researchers at Innsbruck Medical University in Austria tested the ability of the PREDICT-PD algorithm to do so in a community-based cohort representing the general elderly population.